Scarabin P Y, Aillaud M F, Amouyel P, Evans A, Luc G, Ferrières J, Arveiler D, Juhan-Vague I
INSERM, Cardiovascular Epidemiology Unit U258, Hôpital Broussais, Paris, France.
Thromb Haemost. 1998 Nov;80(5):749-56.
The contribution of coagulation factors and fibrinolytic variables to the development of ischaemic arterial disease is still not clearly established. The PRIME study is a prospective cohort study of myocardial infarction in men aged 50-59 years and recruited from three MONICA field centers in France (Lille, Strasbourg and Toulouse) and the center in Northern Ireland (Belfast). Baseline examination included measurement of plasma fibrinogen, factor VII, and PAI-1 activity in over 10,500 participants. We investigated the associations of these haemostatic variables with cardiovascular risk factors, prevalent atherosclerotic disease and geographical area. Fibrinogen level increased with age, smoking, waist-to-hip ratio, LDL-cholesterol, and it decreased with educational level, leisure physical activity, alcohol intake and HDL-cholesterol. Factor VII activity increased with body mass index, waist-to-hip ratio, triglycerides. HDL- and LDL-cholesterol. PAI-1 activity increased with body mass index, waist-to-hip ratio, triglycerides, alcohol intake, smoking, and decreased with leisure physical activity. PAI-1 level was higher in diabetic subjects than in subjects without diabetes. Cardiovascular risk factors explained 8%, 9%, and 26% of the total variance in fibrinogen, factor VII, and PAI-1, respectively. Compared with participants without prevalent cardiovascular disease, those with previous myocardial infarction (n = 280), angina pectoris (n = 230), or peripheral vascular disease (n = 19) had significantly higher levels of fibrinogen. but those with stroke (n = 67) had not. PAI-1 activity showed a similar pattern of association. The odds ratio for cardiovascular disease associated with a rise of a one standard deviation in fibrinogen and PAI-1 was 1.31 (95% confidence interval: 1.20 to 1.42, p <0.001) and 1.38 (95% confidence interval: 1.27 to 1.49, p<0.001), respectively. After adjustment for cardiovascular risk factors, these associations were attenuated but remained highly significant. There was no significant association between factor VII activity and prevalent cardiovascular disease. Fibrinogen level and, to a lesser extent, factor VII and PAI-1 activity were higher in Northern Ireland than France after adjustment for the main cardiovascular risk factors. These geographical variations are consistent with the 2 to 3-fold higher incidence of myocardial infarction in Northern Ireland than France. Our results provide further epidemiological evidence for a possible role of fibrinogen and PAI-1 in the pathogenesis of coronary heart disease.
凝血因子和纤溶变量在缺血性动脉疾病发生发展中的作用仍未明确。PRIME研究是一项针对年龄在50 - 59岁男性心肌梗死的前瞻性队列研究,研究对象招募自法国的三个MONICA现场中心(里尔、斯特拉斯堡和图卢兹)以及北爱尔兰中心(贝尔法斯特)。基线检查包括对超过10500名参与者进行血浆纤维蛋白原、凝血因子VII和纤溶酶原激活物抑制剂-1(PAI-1)活性的测定。我们研究了这些止血变量与心血管危险因素、普遍存在的动脉粥样硬化疾病以及地理区域之间的关联。纤维蛋白原水平随年龄、吸烟、腰臀比、低密度脂蛋白胆固醇升高而升高,随教育水平、休闲体育活动、酒精摄入量和高密度脂蛋白胆固醇降低而降低。凝血因子VII活性随体重指数、腰臀比、甘油三酯、高密度脂蛋白和低密度脂蛋白胆固醇升高而升高。PAI-1活性随体重指数、腰臀比、甘油三酯、酒精摄入量、吸烟升高而升高,随休闲体育活动降低而降低。糖尿病患者的PAI-1水平高于非糖尿病患者。心血管危险因素分别解释了纤维蛋白原、凝血因子VII和PAI-1总变异的8%、9%和26%。与无心血管疾病史的参与者相比,既往有心肌梗死(n = 280)、心绞痛(n = 230)或外周血管疾病(n = 19)的参与者纤维蛋白原水平显著更高,但中风患者(n = 67)并非如此。PAI-1活性呈现出类似的关联模式。纤维蛋白原和PAI-1每升高一个标准差与心血管疾病相关的比值比分别为1.31(95%置信区间:1.20至1.42,p <0.001)和1.38(95%置信区间:1.27至1.49,p<0.001)。在对心血管危险因素进行调整后,这些关联有所减弱但仍高度显著。凝血因子VII活性与普遍存在的心血管疾病之间无显著关联。在对主要心血管危险因素进行调整后,北爱尔兰的纤维蛋白原水平以及程度较轻的凝血因子VII和PAI-1活性高于法国。这些地理差异与北爱尔兰心肌梗死发病率比法国高2至3倍一致。我们的结果为纤维蛋白原和PAI-1在冠心病发病机制中可能发挥的作用提供了进一步的流行病学证据。